Close Menu

NEW YORK (GenomeWeb) – Meridian Bioscience today reported flat fiscal fourth quarter revenues and a 1 percent increase in fiscal year 2016 revenues.

The results were consistent with preliminary earnings announced last month that sent the firm's stock tumbling.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.